Ahmetlic, F. ; Riedel, T. ; Hömberg, N. ; Bauer, V. ; Trautwein, N.* ; Geishauser, A. ; Sparwasser, T.* ; Stevanović, S.* ; Röcken, M.* ; Mocikat, R.
Regulatory T cells in an endogenous mouse lymphoma recognize specific antigen peptides and contribute to immune escape.
Cancer Immunol. Res. 7, 600-608 (2019)
Foxp3+ regulatory T cells (Tregs) sustain immune homeostasis and may contribute to immune escape in malignant disease. As a prerequisite for developing immunologic approaches in cancer therapy, it is necessary to understand the ontogeny and the antigenic specificities of tumor-infiltrating Tregs. We addressed this question by using a λ-MYC transgenic mouse model of endogenously arising B-cell lymphoma, which mirrors key features of human Burkitt lymphoma. We show that Foxp3+ Tregs suppress antitumor responses in endogenous lymphoma. Ablation of Foxp3+ Tregs significantly delayed tumor development. The ratio of Treg to effector T cells was elevated in growing tumors, which could be ascribed to differential proliferation. The Tregs detected were mainly natural Tregs that apparently recognized self-antigens. We identified MHC class II-restricted nonmutated self-epitopes, which were more prevalent in lymphoma than in normal B cells and could be recognized by Tregs. These epitopes were derived from proteins that are associated with cellular processes related to malignancy and may be overexpressed in the tumor.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Selective Depletion; Ifn-gamma; Tolerance; Receptor; Self; Reg; Activation; Mechanisms; Expression; Survival
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2326-6066
e-ISSN
2326-6074
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 7,
Issue: 4,
Pages: 600-608
Article Number: ,
Supplement: ,
Series
Publisher
American Association for Cancer Research (AACR)
Publishing Place
Philadelphia, Pa.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501711-001
G-501700-001
Grants
Copyright
Erfassungsdatum
2019-03-23